» Authors » Veronique De Smedt-Peyrusse

Veronique De Smedt-Peyrusse

Explore the profile of Veronique De Smedt-Peyrusse including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 367
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Walle R, Petitbon A, Fois G, Varin C, Montalban E, Hardt L, et al.
Nat Commun . 2024 Mar; 15(1):2543. PMID: 38514654
Accumulating evidence points to dysregulations of the Nucleus Accumbens (NAc) in eating disorders (ED), however its precise contribution to ED symptomatic dimensions remains unclear. Using chemogenetic manipulations in male mice,...
2.
Jobin M, De Smedt-Peyrusse V, Ducrocq F, Baccouch R, Oummadi A, Pedersen M, et al.
Mol Psychiatry . 2023 Aug; 28(5):2171. PMID: 37550407
No abstract available.
3.
Jobin M, De Smedt-Peyrusse V, Ducrocq F, Baccouch R, Oummadi A, Pedersen M, et al.
Mol Psychiatry . 2023 Jan; 28(5):1960-1969. PMID: 36604603
Increasing evidence supports a relationship between lipid metabolism and mental health. In particular, the biostatus of polyunsaturated fatty acids (PUFAs) correlates with some symptoms of psychiatric disorders, as well as...
4.
Marie A, Leroy J, Darricau M, Alfos S, De Smedt-Peyrusse V, Richard E, et al.
Front Nutr . 2022 Feb; 9:811843. PMID: 35178422
Background: The mechanisms leading to a loss of dopaminergic (DA) neurons from the substantia nigra (SNc) in Parkinson's disease (PD) have multifactorial origins. In this context, nutrition is currently investigated...
5.
Monchaux de Oliveira C, De Smedt-Peyrusse V, Morael J, Vancassel S, Capuron L, Gaudout D, et al.
Pharmaceutics . 2021 Dec; 13(12). PMID: 34959434
Depressive disorders are a major public health concern. Despite currently available treatment options, their prevalence steadily increases, and a high rate of therapeutic failure is often reported, together with important...
6.
Andrianarivelo A, Saint-Jour E, Pousinha P, Fernandez S, Petitbon A, De Smedt-Peyrusse V, et al.
Sci Adv . 2021 Oct; 7(43):eabg5970. PMID: 34669474
Addictive drugs increase dopamine in the nucleus accumbens (NAc), where it persistently shapes excitatory glutamate transmission and hijacks natural reward processing. Here, we provide evidence, from mice to humans, that...
7.
Leyrolle Q, Decoeur F, Dejean C, Briere G, Leon S, Bakoyiannis I, et al.
Glia . 2021 Sep; 70(1):50-70. PMID: 34519378
Westernization of dietary habits has led to a progressive reduction in dietary intake of n-3 polyunsaturated fatty acids (n-3 PUFAs). Low maternal intake of n-3 PUFAs has been linked to...
8.
Ducrocq F, Walle R, Contini A, Oummadi A, Caraballo B, van der Veldt S, et al.
Cell Metab . 2020 Mar; 31(4):755-772.e7. PMID: 32142670
Reward-processing impairment is a common symptomatic dimension of several psychiatric disorders. However, whether the underlying pathological mechanisms are common is unknown. Herein, we asked if the decrease in the n-3...
9.
Ducrocq F, Hyde A, Fanet H, Oummadi A, Walle R, De Smedt-Peyrusse V, et al.
Obesity (Silver Spring) . 2019 Jan; 27(2):255-263. PMID: 30597761
Objective: A growing body of evidence suggests that obesity could result from alterations in reward processing. In rodent models, chronic exposure to an obesogenic diet leads to blunted dopamine signaling...
10.
Naneix F, Darlot F, De Smedt-Peyrusse V, Pape J, Coutureau E, Cador M
Neuropharmacology . 2017 Nov; 129:16-25. PMID: 29146502
Adolescence represents a critical period characterized by major neurobiological changes. Chronic stimulation of the reward system during adolescence might constitute an important factor of vulnerability to pathological development. Increasing evidences...